ClinicalTrials.Veeva

Menu

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

American Regent logo

American Regent

Status and phase

Completed
Phase 3

Conditions

Anemia

Treatments

Drug: Oral iron tablets
Drug: VIT-45

Study type

Interventional

Funder types

Industry

Identifiers

NCT00396292
1VIT03001

Details and patient eligibility

About

This study compares the safety and efficacy of intravenous iron vs oral iron in subjects who display postpartum anemia.

Full description

This is an open label, Phase III, randomized, active controlled study of intravenous iron vs oral iron in anemic post partum patients.

Enrollment

361 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female Subjects able to give consent
  • Post partum patients
  • Baseline Hbg< /= 10
  • Agree to practice birth control
  • Demonstrate willingness to comply with protocol restrictions

Exclusion criteria

  • Known hypersensitivity reaction to oral or IV iron (VIT-45)
  • Documented history of discontinuing oral iron
  • Significant bleeding
  • History of anemia other that iron deficiency anemia
  • Severe Psychiatric disorders
  • Active severe infection
  • Known Hepatitis B antigen or Hep C viral antibody or active hepatitis
  • Known HIV antibody
  • Received investigational product within 30 days
  • Alcohol abuse
  • Hemochromatosis or other iron storage disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

361 participants in 2 patient groups

VIT-45
Experimental group
Description:
A maximum of 1,000 mg iron as IV VIT-45 given at weekly intervals until the the cumulative dose has been reached or a maximum of 2,500 mg has been administered
Treatment:
Drug: VIT-45
Oral iron tablets
Active Comparator group
Description:
325 mg tablets (65 mg elemental iron) with instructions to take 1 tablet by mouth (PO) TID with 8 ounces of tap water, 1 hour before meals from Day 0 until Day 42
Treatment:
Drug: Oral iron tablets

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems